基于家系的Tim-3基因多态性与儿童变应性哮喘的关联研究

目的 以家系资料为基础,利用遗传不平衡原理探讨染色体5q33.2区Tim-3基因启动子两个多态性位点rs10053538和rs10515746与中国湖北地区汉族儿童变应性哮喘的关系.方法 应用限制性片段长度多态性技术结合测序方法,分析了118个儿童变应性哮喘核心家系Tim-3基因rs10053538和rs10515746的基因型;采用基于家系的关联分析方法,包括单体型相对风险分析(HRR)和传递不平衡检验(TDT),分析基因分型数据;应用Transmit软件构建单体型并进行单体型关联分析.结果 118个核心家庭HRR分析显示Tim-3基因启动子区两个多态性位点rs10053538和rs10515746不使病人具有更高的发病风险(X2=2.430,P>0.05;x2=1.368,P>0.05).118个满足经典TDT分析的核心家庭中,杂合子父母传递给患病子代的等位基因频率不比预期值高(x2=2.042,P>O.05;x2=0.750,P>O.05).Transmit双位点单体型分析也未见父母传递给子女各个单体型的观察值和期望值有明显差异(P>O.05).结论 中国湖北地区汉族人群中,Tim-3基因启动子区两个多态性位点rs10053538和rs10515746与儿童变应性哮喘不具有相关性.     

基于家系的Tim-1基因启动子多态性与儿童过敏性哮喘的关联研究

目的:以家系资料为基础,利用遗传不平衡原理探讨染色体5q31-33区Tim-1基因启动子3多态性-2562GA、-416CG和-232GA与湖北地区汉族儿童过敏性哮喘的关系。方法:应用限制性片段长度多态性技术分析了118个儿童过敏性哮喘核心家系Tim-1基因-2562GA、-416CG和-232GA多态性位点的基因型;采用基于家系的传递不平衡检验(TDT)分析基因分型数据;应用TRANSMIT软件构建单倍型并进行单体型关联分析。结果:①118个核心家庭TDT分析显示-2562GA、-232GA位点由杂合子父母传递给患病子代的等位基因频率没有偏离50%,差异无显著性(P0.05),-416CG位点由杂合子父母传递给患病子代的G等位位点的观察值明显高于期望值(P0.05)。②TRANSMIT单体型传递不平衡分析显示父母传递给患病子女GCA和GGA单体型的观察值与期望值差异有显著性(P0.05);Globalχ2检验结果显示Tim-1的单体型与儿童过敏性哮喘有关联(χ2=17.26,P0.01)。结论:Tim-1基因启动子的-416CG位点与中国湖北地区汉族儿童过敏性哮喘易感性相关,由其构建的单体型也与哮喘相关。Tim-1基因遗传多态性可能在哮喘的发病中起重要的作用。     

Molecular variations in the promoter and coding regions of human Tim-1 gene and their association in Koreans with asthma

The family of T-cell immunoglobulin domain and mucin domain (TIM) proteins is identified to be expressed on T cells. A member of Tim family, TIM-1, was considered as a membrane protein that is associated with the development of helper T cell (Th2) biased immune responses, and may be selectively expressed on Th2 cells. In the present study we performed single nucleotide polymorphism (SNP) scanning of the coding and promoter regions of human Tim-1 gene. We identified a total of ten SNPs including five novel SNPs (-1166C>G, -416G>C, -232A>G, 5365C>T, and 5529A>G) in the coding and promoter regions, one novel variation site (-2278_-2276dupATT) in the promoter region and three variations (5383_5397del, 5387_5389insAAC, and 5509_5511delCAA) in exon 4 of human Tim-1 gene. Our results suggest that the exon 4 variation site in human Tim-1 gene is associated with the susceptibility of allergic disease.     

TIM-4基因多态性与湖北地区汉族人群支气管哮喘易感性的研究

目的 探讨T细胞免疫球蛋白域及黏蛋白域蛋白-4(T cells immunoglobulindomain andmucindomain protein-4,TIM-4)基因外显子2区Lys65Lys(G/A)、外显子9区Val1365Met(G/A)的单核昔酸多态性(SNP)与湖北地区汉族人群支气管哮喘易感性的关系.方法 采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)的方法对湖北地区185例哮喘患者和162例健康者TIM-4基因外显子2区Lys65Lys(G/A)、外显子9区Vai365Met(G/A)的多态性进行分析,计算基因型和等位基因频率.结果 (1)湖北地区汉族人群健康者TIM-4基因外显子2区Lys65Lys(G/A)位G/G、G/A、A/A基因型频率分别为0.840、0.160、0,而哮喘人群其频率分别为0.859、0.141、0,其基因型和等位基因型频率与对照组相比差异均无统计学意义(P=0.603,P=0.618);(2)本试验未检测到TIM-4外显子9区Va1365Met(G/A)的多态性.结论 湖北地区汉族人群TIM-4基因外显子2区Lys65Lys(G/A)存在单核苷酸多态性变异,但该位点的变异与湖北地区汉族人群支气管哮喘易感性无关;TIM-4基因外显子9区Va1365Met(G/A)在湖北地区汉族人群中未发现单核苷酸多态性.     

Screening for allergic respiratory disease in the general population with the ADVIA Centaur Allergy Screen Assay

BACKGROUND: In patients in whom the clinical indication for immunoglobulin E (IgE)-mediated allergic respiratory disease is weak, a single qualitative multiallergen-screening assay for IgE antibody to multiple allergen specificities may support the absence of IgE-mediated allergic respiratory disease. The aim was to investigate the diagnostic efficacy of a new multiallergen-screening assay in relation to skin prick test (SPT) reactivity and objective diagnoses of allergic respiratory disease in a general population setting. METHODS: A total of 709 participants in a population-based study were examined by questionnaire and SPT. Serum was analysed by using a multiallergen-screening assay: the ADVIA Centaur Allergy Screen (AS) assay. The dichotomized result of the AS assay was compared with SPT reactivity, specific IgE positivity, and a clinical diagnosis of allergic rhinitis or allergic asthma defined by the presence of relevant symptoms and positive SPTs. RESULTS: Sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) of the AS against SPT reactivity were 86%, 96%, 94%, and 89%, respectively. A negative AS assay test was able to exclude allergic rhinitis and allergic asthma with a probability of more than 96% and 98% (NPV), respectively. The AS assay was able to identify more than 92% and 92% (sensitivity) of cases of allergic rhinitis and allergic asthma, respectively. CONCLUSIONS: The AS assay proved to be a valid measure of allergic respiratory disease and may be used as a screening tool to rule out allergic respiratory disease, and as an objective measure of allergic respiratory disease in epidemiological studies.     

Adenoidectomy and/or tonsillectomy in childhood is not associated with atopic disease later in life

OBJECTIVE: To investigate the association between adenoidectomy and/or tonsillectomy in childhood and asthma, allergic rhinitis (AR), and eczema in adolescence. METHODS: Longitudinal birth cohort study of 1328 members born in the city of Nijmegen. Information on ear-nose-throat surgery was documented at 2, 4, and 8 years of age. In 1055 cohort members the incidence of asthma, AR, and eczema at 21 years of age was determined using the International Study of Asthma and Allergic disease in Childhood Core Questionnaire. To analyse the association between adenoidectomy and/or tonsillectomy in childhood and asthma, AR, and eczema at age 21 years, relative risks (RR) were calculated. RESULTS: Six hundred and ninety-three (66%) members completed the questionnaire at age 21 years, of whom 104 (15%) had undergone adenoidectomy and/or tonsillectomy and 262 (38%) reported atopic disease. Children who underwent adenoidectomy and/or tonsillectomy before the age of 8 years were not more likely to develop asthma, AR, or eczema at the age of 21 years than children who did not; RR 0.93 (95% confidence limits (CL) 0.52-1.64), RR 0.94 (CL 0.68-1.30), and RR 1.00 (CL 0.59-1.68), respectively. CONCLUSIONS: Our data show no association between adenoidectomy and/or tonsillectomy in childhood and the incidence of atopic disease in young adults.     

IgE高亲和力受体β链基因多态性与湖北汉族人变应性哮喘易感性的研究

目的探讨IgE高亲和力受体β链( high-affinity IgE receptor β gene, Fc ε RI β)基因启动子-109位C/T和编码区Glu237Gly基因多态性与湖北汉族人变应性哮喘易感性及血浆总IgE的关系. 方法采用聚合酶链反应-限制性片段长度多态性技术检测 Fc ε RI β基因启动子区-109位和编码区Glu237Gly两位点多态性,采用病例-对照法研究了216例变应性哮喘患者和198名对照. 结果 (1)湖北汉族人变应性哮喘患者 Fc ε RI β基因启动子区-109位T/T、T/C和C/C基因型频率是0.403、0.491和0.106;与对照相比差异无显著性(χ2=0.384,P＞0.05),但变应性哮喘组T/T基因型患者血浆总IgE对数值(2.539±0.8325)与T/C基因型的对数值(2.278±1.089)和C/C基因型的对数值(2.323±0.7852)相比差异具有显著性.(2)变应性哮喘患者 Fc ε RI β基因Glu237Gly位点Glu/Glu、Glu/Gly和Gly/Gly基因型频率为0.579、0.370和0.051,与正常对照相比差异具有显著性(χ2=13.62,P＜0.01),变应性哮喘患者Gly/Gly基因型血浆总IgE对数值为(2.622±0.9374),与Glu/Glu和Glu/Gly相比差异具有显著性. 结论 Fc ε RI β基因启动子区-109位T/T基因型与血浆总IgE高度相关,编码区237位Gly/Gly基因型与中国湖北汉族人变应性哮喘及血浆高IgE相关.     

eotaxin-3基因多态性与变应性哮喘的相关性

目的研究eotaxin-3基因多态性与变应性哮喘的相关性。方法用聚合酶链反应-单链构象多态性-四引物聚合酶链反应-限制性酶切的方法对湖北地区汉族成人eotaxin-3＋77C／T和＋2497T／G单核苷酸多态性与哮喘易感性、嗜酸性粒细胞（eosinophil，EOS）计数以及血浆总IgE水平的相关性进行了分析。结果eotaxin-3＋2497位哮喘组与对照组G等位基因的频率，哮喘组IgE浓度及EOS数量差异有统计学意义，P值分别为0．01l、0．021和0．029；＋77位哮喘组与对照组T等位基因的频率，哮喘组IgE浓度差异无统计学意义，P值分别为0．824和0．473；＋77位哮喘组EOS数量差异有统计学意义，P值为0．044。结论eotaxin-3＋2497T／G多态性与哮喘易感性、EOS数量及IgE水平相关，＋77位C／T基因多态性与哮喘EOS数量相关。     

Autoantibodies against CD28 are associated with atopic diseases

The B7-1/B7-2-CD28/CTLA-4 pathway is crucial in regulating T cell activation and tolerance. Autoantibodies to surface molecules on lymphocytes have already been described in various immune conditions, such as autoimmune diseases, infections and blood transfusions. The objective of this study was to test sera from healthy individuals and from patients for association of CD28 autoantibodies with inflammatory and non-inflammatory diseases. First, CD28 was obtained by digestion of CD28-Ig fusion protein with trypsin. The cleavage products were separated by sodium dodecyl sulphate-page gel electrophoresis. Additionally, a CD28/GST fusion protein was expressed in Escherichia coli and was used to establish an enzyme-linked immunosorbent assay for detection of autoantibodies against CD28. Sera from healthy individuals (n = 72) and patients with different inflammatory and non-inflammatory skin diseases (n = 196) were tested for the presence of autoantibodies against CD28. Using mixed lymphocyte reaction (MLR), purified autoantibodies against CD28 were tested for their effects on CTLA-4-Ig-induced T cell anergy. In this study, for the first time, we describe the existence of autoantibodies against CD28 in humans which are associated with atopic diseases, e.g. allergic rhinitis and asthma. These antibodies stimulate T cells and overcome the CTLA-4-Ig-induced anergy of T cells in an MLR. The existence of autoantibodies against CD28, which may have a T cell-stimulating function, has been shown. The data indicate that autoantibodies against CD28 could be a new immunological mechanism in allergic inflammation. Additionally, autoantibodies against CD28 could be an important new marker to discriminate between atopic diseases and other inflammatory skin diseases.     

Interleukin-18 promoter polymorphism in patients with atopic asthma

Allergic asthma is a chronic inflammatory disease in which interleukin-18 (IL-18) plays an important role. However, there are controversial reports on IL-18 promoter polymorphism as an independent marker of asthma susceptibility. The aim of the present study was to examine the IL-18 promoter polymorphism in patients with allergic asthma. Two hundred and thirty-one patients with allergic asthma from a Polish population diagnosed according to the National Heart, Lung, and Blood Institute (NHLBI)/WHO guidelines were examined. An allele-specific polymerase chain reaction was used to analyse polymorphisms at positions -137 and -607 in the promoter region of the IL-18 gene. Neither in the -607 C>A nor in the -137 G>C promoter polymorphism were there any differences observed between the total group of asthmatic patients and the controls in the frequencies of genotypes, alleles, diplotypes or haplotypes. In patients with severe asthma, the -607 CC and -137 GG genotypes were observed significantly more frequently (P = 0.03 for both), whereas in patients with mild and moderate asthma, the -137 CC genotype was more prevalent than in the former group. The strongest difference between mild to moderate and severe asthma was observed in -137 allele frequencies (P = 0.006). The results of the present study suggest that the -137 G allele and the C-G/C-G diplotype seem to be involved in the pathogenesis of the severe form of asthma.     

The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma

Atopic dermatitis (AD) is an inflammatory disease characterized by pruritic skin lesions. The pathogenesis of AD may include disrupted epidermal barrier function, immunodysregulation, and IgE-mediated sensitization to food and environmental allergens. AD is also part of a process called the atopic march, a progression from AD to allergic rhinitis and asthma. This has been supported by multiple cross-sectional and longitudinal studies and experimental data. Research on the mechanisms of AD has been centered on the adaptive immune system with an emphasis on the T-helper 1 (Th1)-Th2 paradigm. Recently, the conceptual focus has largely shifted to include a primary defect in the epithelial barrier as an initial event in AD providing a significant insight into the disease initiation and pointing to a complex secondary interplay of environmental and immunological sequelae with barrier disruption. Further understanding of AD will help the development of more effective treatment for AD and ultimately, preventative algorithms for the atopic march. In this review we highlight recent advances in our understanding of the pathogenesis of AD and the atopic march.     

FcRL3基因三个单核苷酸多态性与重庆汉族人群Graves病关联研究

目的 了解中国重庆地区汉族人群Fc受体样因子(Fc receptor-like proteins,FcRL3)基因启动子A/G,第2外显子C/G,第4外显子C/T多态性与Graves病(Graves disease,GD)的相关性.方法 采用聚合酶链反应限制性片段长度多态性分析方法结合直接测序技术,对重庆地区无亲缘关系的120名正常人和128例GD患者进行多态性研究,同时进行甲状腺功能和自身抗体的检测,应用Unphased1122和LDA1.0软件进行连锁不平衡和单倍型分析,用卡方检验分析基因型、等位基因和单倍型频率在GD组和对照组之间的差异.结果 GD组FcRL3基因3个多态性位点基因型和等位基因的频率与对照组相比,其差异均有统计学意义(P＜0.05).连锁不平衡分析显示启动子和第2外显子存在连锁不平衡,在构建的3个主要单倍型中,仅H2(G-G)单倍型频率GD组明显高于对照组(50.8%vs 35.8%,P＜0.05).除甲状腺疾病家族史与启动子多态性有关联(P%0.05),余临床特征与FcRL3多态性均无相关.结论 多个位点及单倍型分析提示FcRL3基因启动子A/G,第2外显子C/G,第4外显子C/T多态性可能是中国重庆地区汉族人群GD关联的危险因素.     

Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review

Biomarkers associated with the development of comorbidities in atopic dermatitis (AD) patients have been reported, but have not yet been systematically reviewed. Seven electronic databases were searched, from database inception to September 2021. English language randomized controlled trials, prospective and retrospective cohort, and case–control studies that investigated the association between a biomarker and the development of comorbidities in AD patients were included. Two authors independently screened the records for eligibility, one extracted all data, and critically appraised the quality of studies and risk of bias. Fifty six articles met the inclusion criteria, evaluating 146 candidate biomarkers. The most frequently reported biomarkers were filaggrin mutations and allergen specific-IgE. Promising biomarkers include specific-IgE and/or skin prick tests predicting the development of asthma, and genetic polymorphisms predicting the occurrence of eczema herpeticum. The identified studies and biomarkers were highly heterogeneous, and associated with predominately moderate-to-high risk of bias across multiple domains. Overall, findings were inconsistent. High-quality studies assessing biomarkers associated with the development of comorbidities in people with AD are lacking. Harmonized datasets and independent validation studies are urgently needed.     

Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL

Mannan-binding lectin (MBL), an important component of innate immunity, binds to a range of foreign antigens and initiates the lectin complement pathway. Earlier studies have reported high plasma MBL levels in allergic patients in comparison to healthy controls. In view of varied plasma MBL levels being determined by genetic polymorphisms in its collagen region, we investigated the association of single nucleotide polymorphisms (SNPs) in the collagen region of human MBL with respiratory allergic diseases. The study groups comprised patients of bronchial asthma with allergic rhinitis (n = 49) and allergic bronchopulmonary aspergillosis (APBA) (n = 11) and unrelated age-matched healthy controls of Indian origin (n = 84). A novel intronic SNP, G1011A of MBL, showed a significant association with both the patient groups in comparison to the controls (P < 0.01). Patients homozygous for the 1011A allele showed significantly higher plasma MBL levels and activity than those homozygous for the 1011G allele (P < 0.05). The 1011A allele also showed a significant correlation with high peripheral blood eosinophilia (P < 0.05) and low forced expiratory volume in 1 s (FEV(1)) (P < 0.05) of the patients. We conclude that the 1011A allele of MBL may contribute to elevated plasma MBL levels and activity and to increased severity of the disease markers in patients of bronchial asthma with allergic rhinitis and ABPA.     

IL-6基因多态性与变应性鼻炎的关联性

目的探讨白细胞介素6(IL-6)基因启动子区-634C/G和-572C/G位点多态性与变应性鼻炎的关联性。方法应用聚合酶链反应-限制性片段长度多态性法(PCR-RFLP)检测105例PHC患者和130例健康对照者IL-6基因启动子区-634和-572位点多态性。结果 IL-6基因-634C/G多态性在变应性鼻炎组和对照组的分布差异不显著性(P0.05),而IL-6基因-572C/G多态性在两组人群中的分布差异显著(P0.05)。等位基因频率的相对风险分析发现,G等位基因携带者患冠心病的风险是C等位基因的1.849倍[相对比值比(OR)=1.849,95%可信区间(CI):1.187～2.879]。结论 IL-6-572基因多态性与变应性鼻炎的发病有相关性,G等位基因可能是变应性鼻炎的遗传易感基因。